0001104659-15-033686.txt : 20150604 0001104659-15-033686.hdr.sgml : 20150604 20150504144058 ACCESSION NUMBER: 0001104659-15-033686 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150504 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC CENTRAL INDEX KEY: 0001267565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 780 DEDHAM STREET, SUITE 800 CITY: CANTON STATE: MA ZIP: 02021 BUSINESS PHONE: 781-713-3699 MAIL ADDRESS: STREET 1: 780 DEDHAM STREET, SUITE 800 CITY: CANTON STATE: MA ZIP: 02021 FORMER COMPANY: FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC DATE OF NAME CHANGE: 20031020 CORRESP 1 filename1.htm

 

VIA EDGAR

 

May 4, 2015

 

Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549

 

Re:                 Collegium Pharmaceutical, Inc. (the “Company”)
Registration Statement on Form S-1 (File No. 333-203208)

 

Ladies and Gentlemen:

 

As representatives of the several underwriters of the Company’s proposed public offering of common stock, we hereby join the Company’s request that the effective date of the above-referenced Registration Statement be accelerated so that the above-referenced Registration Statement will be declared effective at 4:00 p.m. New York, New York time on May 6, 2015, or as soon thereafter as is practicable, or at such later time as the Company may orally request via telephone call to the staff of the U.S. Securities and Exchange Commission.

 

Pursuant to Rule 460 of the General Rules and Regulations of the Securities and Exchange Commission under the Securities Act of 1933, as amended, we wish to advise you that we have effected the following distribution of the Company’s Preliminary Prospectus dated April 27, 2015, through the date hereof:

 

Preliminary Prospectus dated April 27, 2015:

 

1,530 copies to prospective underwriters, institutional investors, dealers and others

 

The undersigned advise that they have complied and will continue to comply, and that they have been informed by the participating underwriters and dealers that they have complied with and will continue to comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

 

[Remainder of Page Intentionally Left Blank]

 


 

Very truly yours,

 

 

 

As Representatives of the several Underwriters

 

 

 

JEFFERIES LLC

 

 

 

 

 

By:

/s/ Ashley Delp

 

 

Name:

Ashley Delp

 

 

Title:

Managing

 

 

 

 

 

PIPER JAFFRAY & CO.

 

 

 

 

 

By:

/s/ Christie L. Christina

 

 

Name:

Christie L. Christina

 

 

Title:

Managing Director

 

 

[Signature Page to Acceleration Request]